Kalaris Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KLRS)

Historical Holders from Q1 2025 to Q3 2025

Symbol
KLRS on Nasdaq
CUSIP
482929106
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
18.8M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
13.2M
Holdings value
$76.4M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
31
Number of buys
17
Number of sells
-11
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Kalaris Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KLRS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Samsara BioCapital, L.P. 61.2% $91.9M 11.4M Samsara BioCapital, L.P. Mar 18, 2025
GILEAD SCIENCES, INC. 3.9% $5.81M 723K GILEAD SCIENCES, INC. Mar 18, 2025
Invus Global Management, LLC 1.5% $955K 283K Invus Public Equities, L.P. Jun 30, 2025
EcoR1 Capital, LLC 1.1% $1.62M 202K EcoR1 Capital, LLC Mar 31, 2025

Institutional Holders of Kalaris Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KLRS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 13.2M $76.4M +$1.46M $5.78 31
2025 Q2 13.4M $35.7M -$2.64M $2.67 29
2025 Q1 13.9M $111M +$111M $8.03 31